The Systemic Availability of Oral Glutathione

Overview

Journal Eur J Clin Pharmacol

Specialty Pharmacology

Date 1992 Jan 1

PMID 1362956

Citations 73

Authors

A Witschi

S Reddy

B Stofer

B H Lauterburg

Affiliations

Soon will be listed here.

Abstract

When the plasma glutathione concentration is low, such as in patients with HIV infection, alcoholics, and patients with cirrhosis, increasing the availability of circulating glutathione by oral administration might be of therapeutic benefit. To assess the feasibility of supplementing oral glutathione we have determined the systemic availability of glutathione in 7 healthy volunteers. The basal concentrations of glutathione, cysteine, and glutamate in plasma were 6.2, 8.3, and 54 mumol.l-1 respectively. During the 270 min after the administration of glutathione in a dose of 0.15 mmol.kg-1 the concentrations of glutathione, cysteine, and glutamate in plasma did not increase significantly, suggesting that the systemic availability of glutathione is negligible in man. Because of hydrolysis of glutathione by intestinal and hepatic gamma-glutamyltransferase, dietary glutathione is not a major determinant of circulating glutathione, and it is not possible to increase circulating glutathione to a clinically beneficial extent by the oral administration of a single dose of 3 g of glutathione.

Citing Articles

Effective Repeated Production of γ-glutamylcysteine, Essential For Intracellular Glutathione Production, Using Cellulose-immobilized Phytochelatin Synthase-like Enzyme NsPCS.

Nakai T, Hirata K, Nagano K, Arai M, Uyama H, Hirata Y Appl Biochem Biotechnol. 2025; .

PMID: 39836300 DOI: 10.1007/s12010-024-05137-5.

Minimizing Oxidative Stress in the Lens: Alternative Measures for Elevating Glutathione in the Lens to Protect against Cataract.

Lim J, Jiang L, Lust N, Donaldson P Antioxidants (Basel). 2024; 13(10).

PMID: 39456447 PMC: 11505578. DOI: 10.3390/antiox13101193.

Oral administration of cysteine peptides attenuates UV-B-induced skin erythema and pigmentation in humans.

Sakuma A, Kai Y, Yamasaki Y, Tanaka T, Sakurai T Sci Rep. 2024; 14(1):22163.

PMID: 39333704 PMC: 11436644. DOI: 10.1038/s41598-024-73447-z.

Durian fruit pulp extract enhances intracellular glutathione levels, mitigating oxidative stress and inflammation for neuroprotection.

Khaksar G, Myint S, Hasriadi , Towiwat P, Sirikantaramas S, Rodsiri R Sci Rep. 2024; 14(1):15153.

PMID: 38956206 PMC: 11220076. DOI: 10.1038/s41598-024-65219-6.

Vitamin C and glutathione supplementation: a review of their additive effects on exercise performance.

Lee E, Park H, Kim S, Kim J, Lim K Phys Act Nutr. 2023; 27(3):36-43.

PMID: 37946445 PMC: 10636510. DOI: 10.20463/pan.2023.0027.

References

Bilzer M, Lauterburg B . Effects of hypochlorous acid and chloramines on vascular resistance, cell integrity, and biliary glutathione disulfide in the perfused rat liver: modulation by glutathione. J Hepatol. 1991; 13(1):84-9. DOI: 10.1016/0168-8278(91)90868-c. View

Lauterburg B, Velez M . Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxicity. Gut. 1988; 29(9):1153-7. PMC: 1434362. DOI: 10.1136/gut.29.9.1153. View

Aebi S, Assereto R, Lauterburg B . High-dose intravenous glutathione in man. Pharmacokinetics and effects on cyst(e)ine in plasma and urine. Eur J Clin Invest. 1991; 21(1):103-10. DOI: 10.1111/j.1365-2362.1991.tb01366.x. View

Cantin A, Hubbard R, Crystal R . Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1989; 139(2):370-2. DOI: 10.1164/ajrccm/139.2.370. View

Speisky H, Shackel N, Varghese G, Wade D, Israel Y . Role of hepatic gamma-glutamyltransferase in the degradation of circulating glutathione: studies in the intact guinea pig perfused liver. Hepatology. 1990; 11(5):843-9. DOI: 10.1002/hep.1840110520. View

Newton G, Dorian R, Fahey R . Analysis of biological thiols: derivatization with monobromobimane and separation by reverse-phase high-performance liquid chromatography. Anal Biochem. 1981; 114(2):383-7. DOI: 10.1016/0003-2697(81)90498-x. View

Hagen T, Wierzbicka G, Sillau A, Bowman B, Jones D . Bioavailability of dietary glutathione: effect on plasma concentration. Am J Physiol. 1990; 259(4 Pt 1):G524-9. DOI: 10.1152/ajpgi.1990.259.4.G524. View

Porta P, Aebi S, SUMMER K, Lauterburg B . L-2-oxothiazolidine-4-carboxylic acid, a cysteine prodrug: pharmacokinetics and effects on thiols in plasma and lymphocytes in human. J Pharmacol Exp Ther. 1991; 257(1):331-4. View

Gmunder H, Roth S, Eck H, Gallas H, Mihm S, Droge W . Interleukin-2 mRNA expression, lymphokine production and DNA synthesis in glutathione-depleted T cells. Cell Immunol. 1990; 130(2):520-8. DOI: 10.1016/0008-8749(90)90292-y. View

10.

Chawla R, Lewis F, Kutner M, Bate D, Roy R, RUDMAN D . Plasma cysteine, cystine, and glutathione in cirrhosis. Gastroenterology. 1984; 87(4):770-6. View

11.

Wendel A, Cikryt P . The level and half-life of glutathione in human plasma. FEBS Lett. 1980; 120(2):209-11. DOI: 10.1016/0014-5793(80)80299-7. View

12.

Buhl R, Jaffe H, Holroyd K, WELLS F, Mastrangeli A, Saltini C . Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet. 1989; 2(8675):1294-8. DOI: 10.1016/s0140-6736(89)91909-0. View

13.

Higashi T, Tateishi N, Naruse A, Sakamoto Y . A novel physiological role of liver glutathione as a reservoir of L-cysteine. J Biochem. 1977; 82(1):117-24. DOI: 10.1093/oxfordjournals.jbchem.a131659. View

14.

Burgunder J, Lauterburg B . Decreased production of glutathione in patients with cirrhosis. Eur J Clin Invest. 1987; 17(5):408-14. DOI: 10.1111/j.1365-2362.1987.tb01135.x. View